MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients

被引:44
|
作者
Engbersen, M. P. [1 ,4 ]
van' t Sant, I [1 ]
Lok, C. [2 ]
Lambregts, D. M. J. [1 ]
Sonke, G. S. [3 ]
Beets-Tan, R. G. H. [1 ,4 ]
van Driel, W. J. [2 ]
Lahaye, M. J. [1 ]
机构
[1] Netherlands Canc Inst, Dept Radiol, POB 900203, NL-1006 BE Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Gynecol, Ctr Gynecol Oncol Amsterdam, POB 900203, NL-1006 BE Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Med Oncol, POB 900203, NL-1006 BE Amsterdam, Netherlands
[4] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
关键词
Cytoreductive surgery; Diffusion-weighted MRI; Advanced-stage ovarian cancer; Peritoneal carcinomatosis; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; COMPUTED-TOMOGRAPHY; SURGERY; SURVIVAL; CT; LAPAROSCOPY; METASTASIS;
D O I
10.1016/j.ejrad.2019.03.007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To determine the diagnostic performance of MRI with diffusion-weighted imaging (DW-MRI) in assessing the peritoneal tumor load and predicting whether a complete cytoreduction can be achieved in patients with epithelial ovarian cancer (EOC). Methods: For this observational prospective study, 25 patients with epithelial ovarian cancer scheduled for cytoreductive surgery were included. Patients underwent a 3 T DW-MRI scan prior to surgery. The MR protocol consisted of a T1 and T2 weighted, a contrast-enhanced T1 weighted, and a diffusion-weighted (b0, b1000) sequence. The Peritoneal Cancer Index (PCI) was determined on DW-MR images (MRI-PCI) by two readers, independently, and was compared to the PCI determined during surgery (S-PCI). The inter-observer agreement between the two radiologists was evaluated. In addition, receiver operating characteristics curves were calculated for predicting complete cytoreduction with the S-PCI and MRI-PCI. Results: Staging with DW-MRI showed a correlation to surgical staging with an intraclass correlation coefficient (ICC) 0.86 and 0.85 for reader 1 and 2, respectively. Inter-observer agreement was excellent with an ICC of 0.90 (95% CI: 0.64-0.96). The MRI-PCI scores of reader 1 (AUC = 0.96), reader 2 (AUC = 0.98), and the S-PCI (AUC = 0.92) showed similar predictive values for complete cytoreduction. Conclusion: DW-MRI is accurate in predicting the S-PCI and can be helpful to predict whether a complete resection in ovarian cancer patients is feasible.
引用
收藏
页码:146 / 151
页数:6
相关论文
共 50 条
  • [21] Combined Diffusion-Weighted and Gadolinium-Enhanced MRI Can Accurately Predict the Peritoneal Cancer Index Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures
    Low, Russell N.
    Barone, Robert M.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) : 1394 - 1401
  • [22] Clinical Feasibility of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging with Computed Diffusion-Weighted Imaging Technique in Breast Cancer Patients
    Cho, Eun
    Lee, Jin Hwa
    Baek, Hye Jin
    Ha, Ji Young
    Ryu, Kyeong Hwa
    Park, Sung Eun
    Moon, Jin Il
    Gho, Sung-Min
    Wakayama, Tetsuya
    DIAGNOSTICS, 2020, 10 (08)
  • [23] Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases
    Raphaëla Carmen Dresen
    Sofie De Vuysere
    Frederik De Keyzer
    Eric Van Cutsem
    Hans Prenen
    Ragna Vanslembrouck
    Gert De Hertogh
    Albert Wolthuis
    André D’Hoore
    Vincent Vandecaveye
    Cancer Imaging, 19
  • [24] Concordance of Radiological, Laparoscopic and Laparotomic Scoring to Predict Complete Cytoreduction in Women with Advanced Ovarian Cancer
    Di Donna, Mariano Catello
    Cucinella, Giuseppe
    Zaccaria, Giulia
    Lo Re, Giuseppe
    Crapanzano, Agata
    Salerno, Sergio
    Giallombardo, Vincenzo
    Sozzi, Giulio
    Fagotti, Anna
    Scambia, Giovanni
    Lagana, Antonio Simone
    Chiantera, Vito
    CANCERS, 2023, 15 (02)
  • [25] Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study
    Lambregts, Doenja M. J.
    Vandecaveye, Vincent
    Barbaro, Brunella
    Bakers, Frans C. H.
    Lambrecht, Maarten
    Maas, Monique
    Haustermans, Karin
    Valentini, Vincenzo
    Beets, Geerard L.
    Beets-Tan, Regina G. H.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (08) : 2224 - 2231
  • [26] Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resection
    Sanson, Claire
    Roosen, Alice
    Faron, Matthieu
    Zaccarini, Francois
    Maulard, Amandine
    Scherier, Stephanie
    Pautier, Patricia
    Leary, Alexandra
    Chargari, Cyrus
    Espenel, Sophie
    Genestie, Catherine
    Morice, Philippe
    Gouy, Sebastien
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (05) : 730 - 737
  • [27] Characterization of Primary Mucinous Ovarian Cancer by Diffusion-Weighted and Dynamic Contrast Enhancement MRI in Comparison with Serous Ovarian Cancer
    Grabowska-Derlatka, Laretta
    Derlatka, Pawel
    Halaburda-Rola, Marta
    CANCERS, 2023, 15 (05)
  • [28] The Potential Prognostic Impact of Associated Peritoneal Carcinomatosis in Patients with Stage II and III Epithelial Ovarian Cancer Who Had Upfront Complete Cytoreduction
    Fahim, Mohamed Ibrahim
    Allam, Rasha Mahmoud
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2024, 75 (Suppl 1) : 14 - 17
  • [29] A meta-analysis on the diagnostic value of diffusion-weighted imaging on ovarian cancer
    Dai, Guidong
    Liang, Kali
    Xiao, Zhengyuan
    Yang, Qin
    Yang, Shugen
    JOURNAL OF BUON, 2019, 24 (06): : 2333 - 2340
  • [30] Prediction of overall survival in patients with locally advanced pancreatic cancer using longitudinal diffusion-weighted MRI
    Bisgaard, Anne L. H.
    Brink, Carsten
    Schytte, Tine
    Bahij, Rana
    Ejlsmark, Mathilde Weisz
    Bernchou, Uffe
    Bertelsen, Anders S.
    Pfeiffer, Per
    Mahmood, Faisal
    FRONTIERS IN ONCOLOGY, 2024, 14